Methicillin resistant Staphylococcus aureus (MRSA) infections are responsible for a high number of patient deaths in hospital settings and significantly contribute to health care costs. The reduction of healthcare-associated MRSA infections could potentially improve patient outcome and reduce the level of service, provided test results can be turned around in an adequate time and testing is cost effective. The Sentosa SA Direct MRSA/SA PCR test is a rapid PCR 4-plex assay for the simultaneous detection and differentiation of S. aureus Type I to VII and XI SCCmec/orf X cassettes including mecC. Test results are available after only 2.5 hours with minimum hands-on time due to automated reporting. Differential target detection reduces the number of false positive MRSA results caused by cassette “empty” mecA or S. epidermidis infections. The reliable and cost efficient Sentosa SA Direct MRSA/SA PCR test is well suited for today’s healthcare settings and an excellent alternative to culture methods or more cost-intensive PCR tests.